Ignite Creation Date:
2025-12-24 @ 6:42 PM
Ignite Modification Date:
2025-12-28 @ 7:48 AM
Study NCT ID:
NCT01396057
Status:
COMPLETED
Last Update Posted:
2014-08-07
First Post:
2011-07-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-07
Start Date Type:
None
Primary Completion Date:
2013-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-06
Completion Date Type:
ACTUAL
First Submit Date:
2011-07-14
First Submit QC Date:
None
Study First Post Date:
2011-07-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-06-13
Results First Submit QC Date:
None
Results First Post Date:
2014-07-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-08-04
Last Update Post Date:
2014-08-07
Last Update Post Date Type:
ESTIMATED